Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical utility of urinary gluten immunogenic peptides in the follow-up of patients with coeliac disease.
Garzón-Benavides M, Ruiz-Carnicer Á, Segura V, Fombuena B, García-Fernandez F, Sobrino-Rodriguez S, Gómez-Izquierdo L, Montes-Cano MA, Millan-Domínguez R, Del Carmen Rico M, González-Naranjo C, Bozada-García JM, Coronel-Rodríguez C, Espin B, Díaz J, Comino I, Argüelles-Arias F, Cebolla Á, Romero-Gómez M, Rodriguez-Herrera A, Sousa C, Pizarro-Moreno Á. Garzón-Benavides M, et al. Aliment Pharmacol Ther. 2023 May;57(9):993-1003. doi: 10.1111/apt.17417. Epub 2023 Mar 8. Aliment Pharmacol Ther. 2023. PMID: 36890679
Ustekinumab in Crohn's disease: real-world outcomes and predictors of response.
Lorenzo González L, Valdés Delgado T, Vázquez Morón JM, Castro Laria L, Leo Carnerero E, Maldonado Pérez MB, Sánchez Capilla D, Pallarés Manrique H, Sáez Díaz A, Argüelles Arias F; Grupo de Enfermedad Inflamatoria de Andalucía. Lorenzo González L, et al. Rev Esp Enferm Dig. 2022 May;114(5):272-279. doi: 10.17235/reed.2020.7352/2020. Rev Esp Enferm Dig. 2022. PMID: 33393332 Free article.
Effects of polyphenolic maqui (Aristotelia chilensis) extract on the inhibition of NLRP3 inflammasome and activation of mast cells in a mouse model of Crohn's disease-like colitis.
Ortiz-Cerda T, Argüelles-Arias F, Macías-García L, Vázquez-Román V, Tapia G, Xie K, García-García MD, Merinero M, García-Montes JM, Alcudia A, Witting PK, De-Miguel M. Ortiz-Cerda T, et al. Among authors: arguelles arias f. Front Immunol. 2024 Jan 12;14:1229767. doi: 10.3389/fimmu.2023.1229767. eCollection 2023. Front Immunol. 2024. PMID: 38283356 Free PMC article.
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis.
Rodríguez-Moranta F, Argüelles-Arias F, Hinojosa Del Val J, Iborra Colomino M, Martín-Arranz MD, Menchén Viso L, Muñoz Núñez F, Ricart Gómez E, Sánchez-Hernández JG, Valdés-Delgado T, Guardiola Capón J, Barreiro-de Acosta M, Mañosa Ciria M, Zabana Abdo Y, Gutiérrez Casbas A. Rodríguez-Moranta F, et al. Among authors: arguelles arias f. Gastroenterol Hepatol. 2024 May;47(5):522-552. doi: 10.1016/j.gastrohep.2024.01.007. Epub 2024 Feb 2. Gastroenterol Hepatol. 2024. PMID: 38311005 Free article. English, Spanish.
Performance of a New Rapid Point-of-Care Test for Infliximab Levels in Patients with Inflammatory Bowel Disease: A Comparison to ELISA.
Valdés-Delgado T, Aguado-Paredes A, Merino-Bohórquez V, Martín-Manzanares J, Alonso MM, Maldonado B, Castro L, Belvis M, Benítez B, Caunedo Á, Calleja MÁ, Argüelles-Arias F. Valdés-Delgado T, et al. Among authors: arguelles arias f. Dig Dis Sci. 2024 Jan;69(1):228-234. doi: 10.1007/s10620-023-08139-1. Epub 2023 Nov 9. Dig Dis Sci. 2024. PMID: 37943382 Free PMC article.
Safe use of proton-pump inhibitors.
Martín de Argila de Prados C, López Cardona J, Argüelles-Arias F. Martín de Argila de Prados C, et al. Among authors: arguelles arias f. Rev Esp Enferm Dig. 2023 Sep;115(9):475-479. doi: 10.17235/reed.2023.9834/2023. Rev Esp Enferm Dig. 2023. PMID: 37522310 Free article.
113 results